Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Smith

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Advances in Skin & Wound Care|February 22, 2023
Cross-setting Comparison of Risk Factors for Pressure Injuries Acquired in Post-Acute CareDaniel H Barch, Julie Hayes Seibert, Amy Kandilov, et al.
Cancer Research|May 20, 2016
p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting RadioresistanceOrli Yogev, Karen Barker, Arti Sikka, et al.
Brain Pathology (Zurich, Switzerland)|May 9, 2017
Preclinical transgenic and patient-derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngiomaJessica K R Boult, John R Apps, Annett Hölsken, et al.
Cancer Research|August 14, 2019
<i>In Vivo</i> Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and MetastasisOrli Yogev, Gilberto S Almeida, Karen T Barker, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Advances in Skin & Wound Care|February 22, 2023
Cross-setting Comparison of Risk Factors for Pressure Injuries Acquired in Post-Acute CareDaniel H Barch, Julie Hayes Seibert, Amy Kandilov, et al.
Cancer Research|May 20, 2016
p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting RadioresistanceOrli Yogev, Karen Barker, Arti Sikka, et al.
Brain Pathology (Zurich, Switzerland)|May 9, 2017
Preclinical transgenic and patient-derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngiomaJessica K R Boult, John R Apps, Annett Hölsken, et al.
Cancer Research|August 14, 2019
<i>In Vivo</i> Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and MetastasisOrli Yogev, Gilberto S Almeida, Karen T Barker, et al.
Pageof 2